Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms*♦

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Biological Chemistry

• Publication date

  2012-11-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M112.420224PMID 23132858PMCID PMC3531774
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

  2013cited by this paper
• Alzheimer mechanisms and therapeutic strategies.

  2012cited by this paper
• The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

  2012cited by this paper
• Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.

  2012cited by this paper
• Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes*

  2012cited by this paper
• Heparan Sulphate Proteoglycan and the Low-Density Lipoprotein Receptor-Related Protein 1 Constitute Major Pathways for Neuronal Amyloid-β Uptake

  2011cited by this paper
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease

  2011cited by this paper
• Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance

  2011cited by this paper
• Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

  2010cited by this paper
• Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Mediates Neuronal Aβ42 Uptake and Lysosomal Trafficking

  2010cited by this paper
• Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein

  2010cited by this paper
• Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations.

  2010cited by this paper
• Membrane localization of beta-amyloid 1-42 in lysosomes: a possible mechanism for lysosome labilization.

  2010cited by this paper
• IFN-γ Promotes Complement Expression and Attenuates Amyloid Plaque Deposition in Amyloid β Precursor Protein Transgenic Mice

  2010cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

  2009influential reference
• Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide

  2009cited by this paper
• Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• HIV-1 Accessory Protein Vpu Internalizes Cell-surface BST-2/Tetherin through Transmembrane Interactions Leading to Lysosomes*

  2009cited by this paper
• Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Rab GTPases as coordinators of vesicle traffic

  2009cited by this paper
• Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis

  2009cited by this paper
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease

  2009cited by this paper
• Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease

  2008cited by this paper
• Time-resolved infrared spectroscopy of pH-induced aggregation of the Alzheimer Abeta(1-28) peptide.

  2008cited by this paper
• ApoE and Aβ1–42 interactions

  2007cited by this paper
• Autophagy, amyloidogenesis and Alzheimer disease

  2007cited by this paper
• A Century of Alzheimer's Disease

  2006cited by this paper
• Lysosomal system pathways: Genes to neurodegeneration in Alzheimer's disease

  2006cited by this paper
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome

  2004cited by this paper
• ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.

  2004cited by this paper
• Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

  2004cited by this paper
• Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.

  2004cited by this paper
• Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

  2004cited by this paper
• Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells.

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Lysosomal Membrane Damage in Soluble Aβ-Mediated Cell Death in Alzheimer's Disease

  2001cited by this paper
• The neuronal endosomal-lysosomal system in Alzheimer's disease

  2001cited by this paper
• Isoform-specific Binding of Apolipoprotein E to p-Amyloid*

  2001cited by this paper
• Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

  2000cited by this paper
• Apolipoprotein E: far more than a lipid transport protein.

  2000cited by this paper
• Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1‐42 pathogenesis

  1998cited by this paper
• Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis

  1997cited by this paper
• Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

  1997cited by this paper
• Purification of Apolipoprotein E Attenuates Isoform-specific Binding to -Amyloid (*)

  1995cited by this paper
• Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

  1995cited by this paper
• Isoform-specific binding of apolipoprotein E to beta-amyloid.

  1994cited by this paper
• Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

  1993cited by this paper
• Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.

  1992cited by this paper

• Neuronal age drives β-sheet accumulation and, together with ApoE4, enhances synaptic Aβ localization in APPNL-F neurons

  2026cites this paper
• Age-related macular degeneration and cerebral amyloid angiopathy have similar pathologies from cholesterol-APOE-amyloid-β-complement mediated inflammation.

  2026cites this paper
• Cerebrospinal fluid proteomics for predictive assessment of Alzheimer’s Disease risk

  2025cites this paper
• Lysosomal proteomics reveals mechanisms of neuronal APOE4-associated lysosomal dysfunction

  2025cites this paper
• Multi-functional role of apolipoprotein E in neurodegenerative diseases

  2025cites this paper
• APOE4 impairs autophagy and Aβ clearance by microglial cells

  2025cites this paper
• Neuronal Deletion of Tumor Susceptibility Gene 101 (Tsg101) Causes Rapid Apoptotic Loss of Hippocampal CA3 Neurons

  2025cites this paper
• The APOE–Microglia Axis in Alzheimer’s Disease: Functional Divergence and Therapeutic Perspectives—A Narrative Review

  2025cites this paper
• Decreased IL-33 in the brain following repetitive mild traumatic brain injury contributes to cognitive impairment by inhibiting microglial phagocytosis

  2025cites this paper
• The Synergistic Role of ApoE4 and GSK3β in Alzheimer’s Disease: Pathological Mechanisms and Therapeutic Implications

  2025cites this paper
• Tau Axonal Sorting and Interaction With Synaptic Plasticity Modulators Is Domain‐ and Isoform‐Dependent in Human iPSC‐Derived Neurons

  2025cites this paper
• Axonal Tau sorting depends on the PRR2 domain and 0N4R-specific interactions hint at distinct roles of Tau isoforms in synaptic plasticity

  2024cites this paper
• sAPPα Peptide Promotes Damaged Microglia to Clear Alzheimer's Amyloid-β via Restoring Mitochondrial Function.

  2024cites this paper
• Cell type-specific functions of Alzheimer's disease endocytic risk genes

  2024cites this paper
• Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer's disease by targeted small molecules.

  2024cites this paper
• The Contributions of the Endolysosomal Compartment and Autophagy to APOEɛ4 Allele-Mediated Increase in Alzheimer’s Disease Risk

  2024cites this paper
• Rab11 promotes single Mauthner cell axon regeneration in vivo through axon guidance molecule Ntng2b.

  2024cites this paper
• Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies.

  2024cites this paper
• Endosomal traffic disorders: a driving force behind neurodegenerative diseases

  2024cites this paper
• Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer's Disease.

  2024cites this paper
• iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta

  2024cites this paper
• Emerging microglial biology highlights potential therapeutic targets for Alzheimer's disease.

  2024cites this paper
• Lysosomal proteomics reveals mechanisms of neuronal apoE 4-1 associated lysosomal dysfunction

  2023cites this paper
• A Novel Regulator in Alzheimer's Disease Progression: The Astrocyte-derived Extracellular Vesicles.

  2023cites this paper
• How Single Site Mutations Can Help Understanding Structure Formation of Amyloid β1-40.

  2023cites this paper
• Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood–Brain Barrier Endothelium

  2023cites this paper
• Lysosomal proteomics reveals mechanisms of neuronal apoE4-associated lysosomal dysfunction

  2023cites this paper
• Microtubule acetylation induced by oxidative stress regulates subcellular distribution of lysosomal vesicles for amyloid‐beta secretion

  2023cites this paper
• The exocyst subunit Sec15 is critical for proper synaptic development and function at the Drosophila NMJ.

  2023cites this paper
• Leveraging Plasma Membrane Repair Therapeutics for Treating Neurodegenerative Diseases

  2023cites this paper
• Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer’s disease

  2023cites this paper
• The Multifaceted Role of WNT Signaling in Alzheimer’s Disease Onset and Age-Related Progression

  2023cites this paper
• Rab11A Depletion in Microglia-Derived Extracellular Vesicle Proteome upon Beta-Amyloid Treatment

  2023cites this paper
• Analysis of Cerebral Small Vessel Changes in AD Model Mice

  2022cites this paper
• APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies

  2022cites this paper
• Mechanistic insight into the role of metformin in Alzheimer's disease.

  2022cites this paper
• Amyloid futures in the expanding pathology of brain aging and dementia

  2022cites this paper
• Rab11 and Its Role in Neurodegenerative Diseases

  2022cites this paper
• Amyloid-beta peptides 40 and 42 employ distinct molecular pathways for cell entry and intracellular transit at the BBB endothelium

  2022cites this paper
• Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson’s Disease

  2022cites this paper
• Rabs Mediated Membrane Trafficking in Cancer Progression

  2022cites this paper
• APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

  2022cites this paper
• Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer’s Disease

  2022cites this paper
• Rapid and Gentle Immunopurification of Brain Synaptic Vesicles

  2022cites this paper
• Small GTPases of the Rab and Arf Families: Key Regulators of Intracellular Trafficking in Neurodegeneration

  2021cites this paper
• Long-term running exercise alleviates cognitive dysfunction in APP/PSEN1 transgenic mice via enhancing brain lysosomal function

  2021cites this paper
• Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β.

  2021cites this paper
• Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery.

  2021cites this paper
• Cathepsin D: A Candidate Link between Amyloid β-protein and Tauopathy in Alzheimer Disease

  2021cites this paper
• Extracellular vesicles released by human retinal pigment epithelium mediate increased polarised secretion of drusen proteins in response to AMD stressors

  2021cites this paper
• Opposing functions for retromer and Rab11 in extracellular vesicle traffic at presynaptic terminals

  2021cites this paper
• Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition

  2021cites this paper
• Amyloid β Clearance Is Disrupted by Depletion of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytes

  2021cites this paper
• APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review

  2020cites this paper
• Endocytosis Is a Key Mode of Interaction between Extracellular β-Amyloid and the Cell Membrane.

  2020cites this paper
• Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease

  2020cites this paper
• Degradation Products of Amyloid Protein: Are They The Culprits?

  2020cites this paper
• Vps54 regulates Drosophila neuromuscular junction development and interacts genetically with Rab7 to control composition of the postsynaptic density

  2020cites this paper
• Vps54 regulates Drosophila neuromuscular junction development and controls postsynaptic density composition via a Rab7-dependent mechanism

  2020cites this paper
• Rab11-mediated recycling endosome role in nervous system development and neurodegenerative diseases

  2020cites this paper
• ApoE4: an emerging therapeutic target for Alzheimer’s disease

  2019cites this paper
• The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases

  2019influential citation
• Dynamic effect of beta-amyloid 42 on cell mechanics.

  2019cites this paper
• Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia in vitro

  2019cites this paper
• Proteomic Profiles of the Early Mitochondrial Changes in APP/PS1 and ApoE4 Transgenic Mice Models of Alzheimer's Disease.

  2019cites this paper
• Autophagic and endo-lysosomal dysfunction in neurodegenerative disease

  2019cites this paper
• Proteomic and Unbiased Post-Translational Modification Profiling of Amyloid Plaques and Surrounding Tissue in a Transgenic Mouse Model of Alzheimer’s Disease

  2019cites this paper
• Short-term adverse effects of the apolipoprotein E ε4 allele over language function and executive function in healthy older adults

  2019cites this paper
• GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

  2019cites this paper
• Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.

  2019cites this paper
• Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease

  2019cites this paper
• Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP1

  2019cites this paper
• Is Alzheimer's disease linked to Herpes simplex virus type 1 infection? A mini‐review of the molecular correlation and the possible disease connections

  2019cites this paper
• Ordered and Disordered Segments of Amyloid-β Drive Sequential Steps of the Toxic Pathway.

  2019cites this paper
• ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans

  2019cites this paper
• Opposing functions for retromer and Rab11 in extracellular vesicle cargo traffic at presynaptic terminals

  2019influential citation
• Vacuolar protein sorting protein 41 (VPS41) at an intersection of endosomal traffic in neurodegenerative disease

  2019influential citation
• Distinct functional roles of Vps41‐mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration

  2018cites this paper
• Rab GTPases and Membrane Trafficking in Neurodegeneration

  2018cites this paper
• Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking.

  2018cites this paper
• Characterization of a 3xTg‐AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background

  2018cites this paper
• Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology

  2018cites this paper
• The Interplay Between Apolipoprotein E4 and the Autophagic–Endocytic–Lysosomal Axis

  2018cites this paper
• Consequences of Rab GTPase dysfunction in genetic or acquired human diseases

  2018cites this paper
• Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

  2018cites this paper
• Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer’s disease

  2018cites this paper
• Role of Rab GTPases in Alzheimer's Disease.

  2018cites this paper
• A New Role for ApoE-Not Only in Alzheimer's Disease?

  2018cites this paper
• Rab 11 in Disease Progression

  2018cites this paper
• Advances in developing novel therapeutic strategies for Alzheimer’s disease

  2018cites this paper
• Hemin induces autophagy in a leukemic erythroblast cell line through the LRP1 receptor

  2018cites this paper
• Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish

  2018influential citation
• Determining association of rho kinase 1 gene polymorphisms with risk of Alzheimer's disease: a multicenter pilot study.

  2018cites this paper
• Investigating Amyloid β toxicity in Drosophila melanogaster

  2017cites this paper
• Interactions Between Amyloid-beta and Microglial Cells

  2017cites this paper
• The Regulation of Extracellular Amyloid-β Levels by Ionotropic Glutamatergic Transmission in an Alzheimer’s Disease Mouse Model

  2017influential citation
• NOVEL MODEL FOR LOADING BRAIN IRON IN MICE: IMPLICATIONS FOR STUDYING AGING AND AMYLOID PATHOLOGY

  2017cites this paper
• Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients

  2017cites this paper
• The Endosomal–Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo

  2017cites this paper
• Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition

  2017cites this paper